Formosa Laboratories, Inc. (TPE:4746)
52.20
+1.90 (3.78%)
May 29, 2026, 1:30 PM CST
Formosa Laboratories Revenue
Formosa Laboratories had revenue of 1.06B TWD in the quarter ending March 31, 2026, a decrease of -6.97%. This brings the company's revenue in the last twelve months to 4.77B, up 0.65% year-over-year. In the year 2025, Formosa Laboratories had annual revenue of 4.85B with 2.54% growth.
Revenue (ttm)
4.77B
Revenue Growth
+0.65%
P/S Ratio
1.32
Revenue / Employee
17.04M
Employees
280
Market Cap
6.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.85B | 120.31M | 2.54% |
| Dec 31, 2024 | 4.73B | 370.60M | 8.50% |
| Dec 31, 2023 | 4.36B | 594.94M | 15.80% |
| Dec 31, 2022 | 3.77B | 623.10M | 19.83% |
| Dec 31, 2021 | 3.14B | 66.95M | 2.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Standard Chemical & Pharmaceutical | 7.03B |
| Orient EuroPharma | 4.59B |
| Handa Pharmaceuticals | 1.76B |
| Orient Pharma | 1.41B |
| SCI Pharmtech | 1.36B |
| Allied Biotech | 880.06M |
| Easywell Biomedicals | 682.56M |
| Tien Liang BioTech | 593.46M |